3 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 2 | Unknown 2 |
Follow CLL: new trials by email Literature Review of CLL trials Research Report on CLL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL. GB261 - B Cell NHL, CLL | Phase 1 / Phase 2 | Unknown | Genor Biopharma Co., Ltd. | 460 | 2021-08-31 | 2023-05-22 |
| A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP) GA101/HDMP - CLL | Phase 1 / Phase 2 | Unknown | University of California, San Diego | 40 | 2014-09-01 | 2023-08-30 |
| Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) Lenalidomide and Rituximab - Chronic Lymphocytic Leukemia, CLL | Phase 2 | Unknown | Chronic Lymphocytic Leukemia Research Consortium | 80 | 2008-02-01 | 2010-09-10 |
Leukemia, Lymphocytic, Chronic, B-Cell (1)
Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Lenalidomide (1) · Rituximab (1)
Chronic Lymphocytic Leukemia Research Consortium (1) · Genor Biopharma Co., Ltd. (1) · University of California, San Diego (1)
United States (2) · Australia (1)
Danelle F James, M.D. (1) · Kipps Thomas, MD (1) · Thomas J Kipps, M.D., Ph.D (1)